*For investigators interested in applying for the FOA's listed below, there will be two webinars held on September 11th and 16th, 2014           at 1:00 PM (EDT) explaining each of the funding opportunities and allowing for a Q&A session. Applicants need only attend one of the two       webinars. Please register ahead of time. 

 

Data and Sample Requests

There are two ways to access data and samples from the DCCT/EDIC Study. One is via the NIDDK Repositories, which have data and samples available for distribution through 2011. The second is to apply to collaborate with the EDIC Study.

 

Accessing samples via the NIDDK Repository

 

Collaborating with the EDIC Study

All collaborators should agree to the EDIC Publications and Presentations Policy and the Ancillary Studies Policies that are contained in Chapter 8 of the EDIC Protocol.

Letter from the DCCT/EDIC Study Chairman

 

NIDDK Funding Opportunities for Collaborative Studies

Title: Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of NIDDK (R01)

Funding Opportunity Announcement (FOA) Number: PAR-12-265

 

Title: Research Using Subjects from Selected Type 1 Diabetes Clinical Studies (Living Biobank) (DP3)*

Funding Opportunity Announcement (FOA) Number: PAR-14-258

 

Title: Research Using Biosamples from Selected Type 1 Diabetes Clinical Studies (DP3)*

Funding Opportunity Announcement (FOA) Number: PAR-14-257

 

Feasibility Statement*

Prospective investigators should be aware that there is a finite quantity of specimens in both the EDIC Central Biochemistry Laboratory (CBL) and the NIDDK Repository, and some samples may have been depleted or may have very low volumes. Therefore, a sample of subjects with available specimens may be a biased representation of the DCCT/EDIC cohort. Availiability of adequate numbers of subjects with available specimens will be a criteria on which the Research Review Committee (RRC) will base their evaluations of a new proposal. 

Urine, Plasma, and Serum at the Repository as of September 22nd, 2014

Urine, Plasma, and Serum at the CBL as of October 6th, 2014

Characteristics and Complications for Those Who Agreed or Refused to Send Samples to the Repository

 

*Potential collaborators may require information to allow them to best evaluate the possibilities for collaborations with EDIC or to plan the design (e.g. sample size) for a study. Investigators who would like to obtain specific numbers of cases of specific outcomes that have occurred during EDIC should contact Ms. Patricia A. Cleary at cleary@bsc.gwu.edu.